This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Humana (HUM) Soars 3.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Humana (HUM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
by Zacks Equity Research
ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
FTC Report Reveals PBM Practices Impacting Competition and Drug Costs
by Zacks Equity Research
The report comes at a time when insurers are grappling with rising medical costs.
Cigna Stock Plunges 18.7% in 3 Months: Should You Buy, Hold or Sell?
by Zacks Equity Research
Despite market challenges, CI's strong fundamentals and growth drivers make it worth holding for long-term investors looking to capitalize on future recovery opportunities.
Healthcare Executives Bullish on 2025: But Why Are Stocks Slipping?
by Kaibalya Pravo Dey
Improving the consumer experience, engagement and trust is emerging as a top strategy for healthcare companies.
SEM Plunges 48.2% in 6 Months: Should You Buy, Hold or Sell the Stock?
by Zacks Equity Research
Rising expenses and high leverage are impacting Select Medical's prospects.
Here's Why Cigna (CI) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Top Research Reports for ServiceNow, AMD & Sanofi
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Advanced Micro Devices, Inc. (AMD) and Sanofi (SNY), as well as two micro-cap stocks Team, Inc. (TISI) and United-Guardian, Inc. (UG).
Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?
by Kaibalya Pravo Dey
ELV is reallocating resources to more profitable areas and making prudent acquisitions.